Sam Salek

发表

Content Validation by Patients and Experts: Is the PRO Measure Fit for Purpose?

Paul Kamudoni, Nutjaree Pratheepawanit Johns, Sam Salek, 2018 .

Implementation of the Benefit–Risk Summary Template by a Maturing Agency: A Case Study

Sam Salek, James Leong, Stuart Walker, 2015 .

Development and Application of a Benefit–Risk Assessment Model Based on Multi‐Criteria Decision Analysis

Sam Salek, Stuart Walker, Filip Mussen, 2009 .

Evaluating Quality of Decision-Making Processes in Medicines' Development, Regulatory Review, and Health Technology Assessment: A Systematic Review of the Literature

Sam Salek, Stuart R. Walker, Magdalena Bujar, 2017, Front. Pharmacol..

Approaches to the Development and Use of PRO Measures: A New Roadmap

Paul Kamudoni, Nutjaree Pratheepawanit Johns, Sam Salek, 2018 .

Approaches to Utilizing Decision-Making Framework

Stuart Walker, Sam Salek, James Leong, 2015 .

Optimisation of discharge communication: a key to successful outcome

Sam Salek, R. Samson, J. Gilbertson, 2007 .

Conceptualisation and Qualitative Development of a PRO Measure

Paul Kamudoni, Nutjaree Pratheepawanit Johns, Sam Salek, 2018 .

Review of the Current Benefit–Risk Assessment Models

Sam Salek, Stuart Walker, Filip Mussen, 2009 .

Retracted:A quantitative approach to benefit‐risk assessment of medicines — part 2: the practical application of a new model

Sam Salek, Stuart Walker, Filip Mussen, 2007, Pharmacoepidemiology and drug safety.

A quantitative approach to benefit‐risk assessment of medicines – part 1: the development of a new model using multi‐criteria decision analysis

Sam Salek, Stuart Walker, Filip Mussen, 2007, Pharmacoepidemiology and drug safety.

Benefit-Risk Appraisal of Medicines

Sam Salek, Stuart Walker, Filip Mussen, 2008 .

A quantitative approach to benefit-risk assessment of medicines - part 2: the practical application of a new model (vol 16, pg S16, 2007)

Stuart Walker, Sam Salek, Stuart Walker, 2007 .

A quantitative approach to benefit‐risk assessment of medicines—part 1: the development of a new model using multi‐criteria decision analysis; part 2: the practical application of a new model

Sam Salek, Stuart Walker, Filip Mussen, 2007, Pharmacoepidemiology and drug safety.

016 Ordinal logistic regression and Monte Carlo simulation in the mapping of DLQI scores to EQ-5D utility values

Sam Salek, Andrew Yule Finlay, Richard Kay, 2016 .

Benefit-Risk Appraisal of Medicines: A Systematic Approach to Decision-making

Sam Salek, Stuart Walker, Filip Mussen, 2010 .